Fulcrum Therapeutics, Inc.’s Dividend Yield at a glance
Fulcrum Therapeutics, Inc. reports dividend yield of 0% for Dec 2024. The prior period recorded 0% (Dec 2023). Year over year the metric moved +0 pts. The rolling three-period average stands at 0%. Data last refreshed Dec 7, 2025, 2:46 AM.
Latest reading
0% · Dec 2024
YoY movement
+0 pts
Rolling average
0%
Current Dividend Yield
0%
+0 pts
–
Rolling average
0%
Latest Value
0%
Dec 2024
YoY Change
+0 pts
Absolute
YoY Change %
–
Rate of change
3-Period Avg
0%
Smoothed
Narrative signal
Fulcrum Therapeutics, Inc.’s dividend yield stands at 0% for Dec 2024. Year-over-year, the metric shifted by +0 pts, translating into a – rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How dividend yield shapes Fulcrum Therapeutics, Inc.'s story
As of Dec 2024, Fulcrum Therapeutics, Inc. reports dividend yield of 0%. Review annual dividend yield trends, payout momentum, and shareholder income strength for leading U.S. equities.
What dividend yield tells investors
Dividend yield shows how much cash flow a shareholder earns relative to the stock price. A rising yield can indicate improving capital returns but may also signal share price weakness.
How to interpret momentum
Compare the latest dividend yield against the 3-year history to understand consistency. Large swings often reflect changes in payout policy or volatile share price performance.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
98%
Operating Margin
-27.4%
Net Profit Margin
-12.2%
Return on Equity
-4%
Return on Assets
-3.7%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Fulcrum Therapeutics, Inc. (FULC) FAQs
Answers tailored to Fulcrum Therapeutics, Inc.’s dividend yield profile using the latest Financial Modeling Prep data.
What is Fulcrum Therapeutics, Inc.'s current dividend yield?
As of Dec 2024, Fulcrum Therapeutics, Inc. reports dividend yield of 0%. This reading reflects the latest filings and price data for FULC.
How is Fulcrum Therapeutics, Inc.'s dividend yield trending year over year?
Year-over-year, the figure shifts by +0 pts. Pair this context with revenue growth and free cash flow signals to gauge momentum for FULC.
Why does dividend yield matter for Fulcrum Therapeutics, Inc.?
Dividend yield tracks cash returned to shareholders as a percentage of the current share price. For Fulcrum Therapeutics, Inc., operating within Healthcare — Biotechnology, tracking this metric helps benchmark management's execution against close competitors.
Is Fulcrum Therapeutics, Inc.'s dividend yield above its recent average?
Fulcrum Therapeutics, Inc.'s rolling three-period average sits at 0%. Comparing the latest reading of 0% to that baseline highlights whether momentum is building or fading for FULC.
How frequently is Fulcrum Therapeutics, Inc.'s dividend yield refreshed?
Data for FULC was last refreshed on Dec 7, 2025, 2:46 AM and updates automatically every 24 hours, keeping your valuation inputs current.